Search Results - Florence Boissière‐Michot

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
    Oestrogen receptor negative breast cancers exhibit high cytokine content

    Oestrogen receptor negative breast cancers exhibit high cytokine content by Carine Chavey, Frédéric Bibeau, S. Gourgou-Bourgade, Sandrine Burlinchon, Florence Boissière‐Michot, Daniel Laune, Sylvie Roques, Gwendal Lazennec

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Prognostic Value of HER2-Low Expression in Non-Metastatic Triple-Negative Breast Cancer and Correlation with Other Biomarkers

    Prognostic Value of HER2-Low Expression in Non-Metastatic Triple-Negative Breast Cancer and Correlation with Other Biomarkers by William Jacot, Aurélie Maran-Gonzalez, Océane Massol, Charlotte Sorbs, Caroline Mollévi, Séverine Guiu, Florence Boissière‐Michot, José Ramos

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Prognostic Value of Trop‐2 Expression in Nonmetastatic Triple‐Negative Breast Cancer and Correlation With Emerging Biomarkers

    Prognostic Value of Trop‐2 Expression in Nonmetastatic Triple‐Negative Breast Cancer and Correlation With Emerging Biomarkers by William Jacot, Marie-Christine Château, Simon Thézenas, Séverine Guiu, Nelly Firmin, Virginie Lafont, Gwendal Lazennec, Charles Theillet, Florence Boissière‐Michot

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Inferring ligand-receptor cellular networks from bulk and spatial transcriptomic datasets with BulkSignalR

    Inferring ligand-receptor cellular networks from bulk and spatial transcriptomic datasets with BulkSignalR by Jean-Philippe Villemin, Laia Bassaganyas, Didier Pourquier, Florence Boissière‐Michot, Simon Cabello‐Aguilar, Evelyne Lopez‐Crapez, Rita Tanos, Emmanuel Cornillot, Andrei Turtoï, Jacques Colinge

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Cancer-associated fibroblast spatial heterogeneity and <i>EMILIN1</i> expression in the tumor microenvironment modulate TGF-β activity and CD8<sup>+</sup> T-cell infiltration in breast cancer

    Cancer-associated fibroblast spatial heterogeneity and <i>EMILIN1</i> expression in the tumor microenvironment modulate TGF-β activity and CD8<sup>+</sup> T-cell infiltration in br... by Chikako Honda, Sasagu Kurozumi, Takaaki Fujii, Didier Pourquier, Lakhdar Khellaf, Florence Boissière‐Michot, Jun Horiguchi, Tetsunari Oyama, Ken Shirabe, Jacques Colinge, Takehiko Yokobori, Andrei Turtoï

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Breast tumor PDXs are genetically plastic and correspond to a subset of aggressive cancers prone to relapse

    Breast tumor PDXs are genetically plastic and correspond to a subset of aggressive cancers prone to relapse by Stanislas du Manoir, Béatrice Orsetti, Rui Bras-Gonçalves, Tien-Tuan Nguyen, Laurence Lasorsa, Florence Boissière‐Michot, Blandine Massemin, Pierre‐Emmanuel Colombo, Frédéric Bibeau, William Jacot, Charles Theillet

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Characterization of an adaptive immune response in microsatellite-instable colorectal cancer

    Characterization of an adaptive immune response in microsatellite-instable colorectal cancer by Florence Boissière‐Michot, Gwendal Lazennec, Hélène Frugier, Marta Jarlier, Lise Roca, Jacqueline Duffour, Emilie Du Paty, Daniel Laune, France Blanchard, Florence Le Pessot, Jean‐Christophe Sabourin, Frédéric Bibeau

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    <scp>HER</scp>2 overexpression a major risk factor for recurrence in pT1a‐bN0M0 breast cancer: results from a <scp>F</scp>rench regional cohort

    <scp>HER</scp>2 overexpression a major risk factor for recurrence in pT1a‐bN0M0 breast cancer: results from a <scp>F</scp>rench regional cohort by Philippe Rouanet, Pascal Roger, Emilie Rousseau, Severine Thibault, Gilles Romieu, Andre Mathieu, Jacques Cretin, G Barnéon, M. Granier, Aurélie Maran-Gonzalez, Jean Pierre Daurès, Florence Boissière‐Michot, Frédéric Bibeau

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers

    Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers by Séverine Guiu, Caroline Mollévi, Céline Charon‐Barra, Florence Boissière‐Michot, Evelyne Lopez‐Crapez, Elodie Chartron, Pierre‐Jean Lamy, Marian Gutowski, C. Bourgier, Gilles Romieu, Joëlle Simony-Lafontaine, William Jacot

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Increased expression of class III β-tubulin in castration-resistant human prostate cancer

    Increased expression of class III β-tubulin in castration-resistant human prostate cancer by Stéphane Terry, Guillaume Ploussard, Yves Allory, Nathalie Nicolaı̈ew, Florence Boissière‐Michot, Patrick Maillé, Laurence Kheuang, Estelle Coppolani, Adnan Ali, Frédéric Bibeau, Stéphane Culine, Ralph Buttyan, Alexandre de la Taille, Francis Vacherot

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Clinical Correlations of Programmed Cell Death Ligand 1 Status in Liquid and Standard Biopsies in Breast Cancer

    Clinical Correlations of Programmed Cell Death Ligand 1 Status in Liquid and Standard Biopsies in Breast Cancer by William Jacot, Martine Mazel, Caroline Mollévi, Stéphane Pouderoux, Véronique D’Hondt, Laure Cayrefourcq, C. Bourgier, Florence Boissière‐Michot, Fella Berrabah, Evelyne Lopez‐Crapez, François‐Clément Bidard, Marie Viala, Thierry Maudelondé, Séverine Guiu, Catherine Alix‐Panabières

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy

    TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy by A. Oden-Gangloff, F. Di Fiore, Frédéric Bibeau, A. Lamy, Gaëlle Bougeard, F. Charbonnier, Frédéric Blanchard, David Tougeron, Marc Ychou, Florence Boissière‐Michot, Florence Le Pessot, J-C Sabourin, J‐J Tuech, Pierre Michel, Thierry Frébourg

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Targeting the p38 MAPK Pathway Inhibits Irinotecan Resistance in Colon Adenocarcinoma

    Targeting the p38 MAPK Pathway Inhibits Irinotecan Resistance in Colon Adenocarcinoma by Salomé Paillas, Florence Boissière‐Michot, Frédéric Bibeau, Amélie Denouël, Caroline Mollévi, Annick Causse, Vincent Denis, Nadia Vezzio-Vié, Laetitia Marzi, Cédric Cortijo, Imade Aït-Arsa, Nadav Askari, Philippe Pourquier, Pierre Martineau, Maguy Del Rio, Céline Gongora

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    TOM1L1 drives membrane delivery of MT1-MMP to promote ERBB2-induced breast cancer cell invasion

    TOM1L1 drives membrane delivery of MT1-MMP to promote ERBB2-induced breast cancer cell invasion by Clément Chevalier, Guillaume Collin, Simon Descamps, Heiani Touaitahuata, Valérie Simon, Nicolas Reymond, Laurent Fernandez, Pierre‐Emmanuel Milhiet, Virginie Georget, Serge Urbach, Laurence Lasorsa, Béatrice Orsetti, Florence Boissière‐Michot, Evelyne Lopez‐Crapez, Charles Theillet, Serge Roche, Christine Bénistant

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Antibody targeting of claudin-1 as a potential colorectal cancer therapy

    Antibody targeting of claudin-1 as a potential colorectal cancer therapy by Sara Cherradi, Adeline Ayrolles-Torro, Nadia Vezzo-Vié, N. Gueguinou, Vincent Denis, Eve Combès, Florence Boissière‐Michot, Muriel Busson, Lucile Canterel-Thouennon, Caroline Mollévi, Martine Pugnière, Frédéric Bibeau, Marc Ychou, Pierre Martineau, Céline Gongora, Maguy Del Rio

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial

    Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial by Emmanuelle Samalin, Olivier Bouché, Simon Thézenas, Éric François, Antoine Adenis, Jaafar Bennouna, Julien Taı̈eb, Françoise Desseigne, J. F. Seitz, Thierry Conroy, Marie‐Pierre Galais, Eric Assénat, Evelyne Lopez‐Crapez, Sylvain Poujol, Frédéric Bibeau, Florence Boissière‐Michot, Pierre Laurent–Puig, Marc Ychou, Tessa Mazard

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    FTO-mediated cytoplasmic m6Am demethylation adjusts stem-like properties in colorectal cancer cell

    FTO-mediated cytoplasmic m6Am demethylation adjusts stem-like properties in colorectal cancer cell by Sébastien Relier, Julie Ripoll, Hélène Guillorit, Amandine Amalric, Cyrinne Achour, Florence Boissière‐Michot, Jérôme Vialaret, Aurore Attina, Françoise Debart, Armelle Choquet, Françoise Macari, Virginie Marchand, Yuri Motorin, Emmanuelle Samalin, Jean‐Jacques Vasseur, Julie Pannequin, Francesca Aguiló, Evelyne Lopez‐Crapez, Christophe Hirtz, Éric Rivals, Amandine Bastide, Alexandre David

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Immune and gene-expression profiling in estrogen receptor low and negative early breast cancer

    Immune and gene-expression profiling in estrogen receptor low and negative early breast cancer by Davide Massa, Claudio Vernieri, Lorenzo Nicolè, Carmen Criscitiello, Florence Boissière‐Michot, Séverine Guiu, Angélique Bobrie, Gaia Griguolo, Federica Miglietta, Andrea Vingiani, Riccardo Lobefaro, Beatrice Taurelli Salimbeni, Claudia Pinato, Francesca Schiavi, Silvia Brich, Carlo Pescia, Nicola Fusco, Giancarlo Pruneri, Matteo Fassan, Giuseppe Curigliano, Valentina Guarneri, William Jacot, Maria Vittoria Dieci

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies

    Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies by Yahya Ashraf, Hanane Mansouri, Valérie Laurent‐Matha, Lindsay B. Alcaraz, Pascal Roger, Séverine Guiu, Danielle Derocq, Gautier Robin, Henri‐Alexandre Michaud, Hélène Delpech, Marta Jarlier, Martine Pugnière, Bruno Robert, Anthony Puel, Lucie Martin, Flavie Landomiel, Thomas Bourquard, Oussama Achour, Ingrid Fruitier‐Arnaudin, Alexandre Pichard, Emmanuel Deshayes, Andrei Turtoï, Anne Poupon, Joëlle Simony-Lafontaine, Florence Boissière‐Michot, Nelly Pirot, Florence Bernex, William Jacot, Stanislas du Manoir, Charles Theillet, Jean‐Pierre Pouget, Isabelle Navarro‐Teulon, Nathalie Bonnefoy, André Pèlegrin, Thierry Chardès, Pierre Martineau, Emmanuelle Liaudet‐Coopman

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: